Intelligence Platform

Patents

Browse 379 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7674778

Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674779

RNAi modulation of MLL-AF4 and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632932

Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7626014

Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7615618

Oligonucleotides comprising a non-phosphate backbone linkage

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605251

Compositions and methods for inhibiting expression of the PCSK9 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592322

RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582744

Chemically modified oligonucleotides

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582745

Compositions and methods for inhibiting expression of Nav1.8 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579451

Oligonucleotides comprising a modified or non-natural nucleobase

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528118

RNAi modulation of ApoB and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517865

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507809

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473525

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Europe AG · Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7423142

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361752

RNAi modulation of MLL-AF4 and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348314

Compositions and methods for inhibiting viral replication

Alnylam Europe AG · Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7320965

Compositions and methods for inhibiting expression of Huntingtin gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7196184

Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8

Alnylam Europe AG · Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted